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ABSTRACT
Transthyretin (TTR) is the major T4-binding protein in rodents.
Using a TTR-null mouse model we asked the following questions.
1) Do other T4 binding moieties replace TTR in the cerebrospinal
fluid (CSF)? 2) Are the low whole brain total T4 levels found in this
mouse model associated with hypothyroidism, e.g. increased 59-
deiodinase type 2 (D2) activity and RC3-neurogranin messenger
RNA levels? 3) Which brain regions account for the decreased total
whole brain T4 levels? 4) Are there changes in T3 levels in the brain?
Our results show the following. 1) No other T4-binding protein
replaces TTR in the CSF of the TTR-null mice. 2) D2 activity is
normal in the cortex, cerebellum, and hippocampus, and total brain
RC3-neurogranin messenger RNA levels are not altered. 3) T4
levels measured in the cortex, cerebellum, and hippocampus are
normal. However T4 and T3 levels in the choroid plexus are only
14% and 48% of the normal values, respectively. 4) T3 levels are
normal in the brain parenchyma. The data presented here suggest
that TTR influences thyroid hormone levels in the choroid plexus,
but not in the brain. Interference with the blood-choroid-plexus-
CSF-TTR-mediated route of T4 entry into the brain caused by the
absence of TTR does not produce measurable features of hypothy-
roidism. It thus appears that TTR is not required for T4 entry or
for maintenance of the euthyroid state in the mouse brain. (En-
docrinology 141: 3267–3272, 2000)
TRANSTHYRETIN (TTR) is a 55-kDa tetrameric protein(1) synthesized mainly by liver and the choroid plexus
of the brain, a membrane specialized in the production of
cerebrospinal fluid (CSF) (2). TTR expression, an early event
in embryonic development, first occurs in the choroid plexus
and later in the liver (3, 4). TTR, which represents about 20%
of the total protein synthesized by the choroid plexus, is
secreted into the CSF (5). As much as 25% of total CSF protein
consists of TTR (6).
TTR is the major plasma carrier of thyroid hormones in
rodents (7) and is the main thyroid hormone-binding protein
in CSF of both rodent and humans (8). The high concentra-
tion of TTR in the CSF suggested a major role for TTR in
mediating T4 transfer from the blood into the brain across the
blood-choroid-plexus-CSF barrier (9–13).
Thyroid hormones are essential for normal mammalian
brain physiology and are particularly critical during devel-
opment (14–16). Moreover, the adult brain is sensitive to
thyroid hormones beyond the time of the so-called critical
period of brain development. More than half of the T3 (the
biologically active thyroid hormone) in the cerebral cortex
arises from local deiodination of T4 by the enzymatic action
of type 2 iodothyronine 59-deiodinase (D2) (17, 18). In hy-
pothyroidism, the brain compensates for the low levels of
circulating hormones by increasing D2 activity (19). T4 or T3
can regulate brain D2 through both pre- and posttransla-
tional mechanisms (20). Among the molecular events known
to be controlled by thyroid hormones in the adult brain is the
transcription of the RC3 gene, whose product is a brain-
specific, calmodulin-binding protein kinase C substrate that
has been implicated in postsynaptic events (21). A thyroid
hormone-responsive element has been found in the human
RC3 gene homolog (22). Previous analysis of thyroid hor-
mone metabolism markers (23) revealed that TTR-null mice
are hypothyroxinemic, but euthyroid (24). In addition, ki-
netic studies using [125I]T4 showed that TTR is not essential
for T4 uptake by the brain and other tissues (25). However,
lower total T4 levels were detected in the TTR-null whole
brain. In the present work we use the TTR-null mouse strain
to study further the involvement of TTR in the maintenance
of thyroid hormone homeostasis in the brain.
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Materials and Methods
Animals
Animals were handled in accordance with the NIH guidelines and the
European Union rules for the care and handling of laboratory animals.
Two- to 4-month-old 129 SV wild-type and TTR-null male mice (23) were
kept under a 12-h light cycle and fed regular rodent chow and tap water
ad libitum. Mice were anesthetized with ketamine/xylazine and killed by
cardiac puncture, and brain and sera were immediately frozen in dry ice
and kept at 270 C for further analysis. CSF was collected from the
cisterna magna and pooled from several animals. An aliquot was kept
for blood contamination analysis, and the remainder was immediately
frozen at 270 C. No CSF samples were contaminated, in accordance with
criteria previously described (26).
In vitro choroid plexus labeling
Pools of choroid plexuses from three wild-type or TTR-null mice were
incubated in 300 ml leucine-free medium (DMEM, Life Technologies,
Inc., Paisley, UK) containing 15 mCi [14C]leucine (Amersham Pharmacia
Biotech, Uppsala, Sweden; SA, 319 mCi/mmol). After 3-h incubation in
5% CO2 at 37 C, cell pellets were resuspended in medium containing
0.1% Tween. Radioactive proteins present in both secretion media and
cells were separated on SDS-PAGE gels and analyzed by autoradiog-
raphy. As a standard we used a preparation containing 125I-radiolabeled
TTR and retinol-binding protein.
T4 binding to CSF proteins
Native gel electrophoresis. Aliquots of 13 ml pooled CSF and 5 ml serum
were incubated for 30 min at room temperature with 12 ml [125I]T4
(DuPont, Wilmington, DE; 5700 mCi/mg) diluted 4-fold in 200 mm gly-
cine and 130 mm sodium acetate, pH 8.6 (7) and subjected to electro-
phoresis on 8% native polyacrylamide gels, using the same glycine-
acetate as gel and running buffer, for 3–5 h at 40 mA at room
temperature. The migration of albumin was determined in a serum
sample incubated with bromophenol blue run on a different gel lane.
Radioactive proteins were visualized by autoradiography 4 h after
exposure.
In another experiment, 40 ml CSF were applied on a blue-Sepharose
(Amersham Pharmacia Biotech) column (300-ml volume) equilibrated in
30 mm sodium phosphate, pH 7.0. The bound material was eluted in 0.5
m sodium thiocyanate in 30 mm sodium phosphate, pH 7.0. Both the
bound- and unbound fractions were concentrated on Microcon 10 (Ami-
con, Beverly, MA) and then incubated with [125I]T4 and analyzed by
electrophoresis as described above.
Chromatography on Biogel P-6 DG. Seventeen microliters of pooled CSF
were incubated for 4 h at 4 C with 105 cpm [125I]T4 (DuPont; SA, 1250
mCi/mg) in TNE buffer (100 mm Tris, 100 mm NaCl, and 1 mm EDTA,
pH 8.0; 200-ml final volume). Samples were applied to 1-ml Biogel P-6
DG columns (Bio-Rad Laboratories, Inc., Hercules, CA) (27) in TNE
buffer immediately after loading 200 ml TNE/20% sucrose and were
centrifuged for 1 min at 1000 rpm. The columns were then washed with
200 ml TNE, and the eluates, containing the protein-bound [125I]T4 were
counted in a g-counter. Free [125I]T4 remained bound to the gel, allowing
calculation of the percentage of protein-bound [125I]T4 in CSF. A blank
consisted of 106 cpm [125I]T4 in TNE buffer; the eluate of this preparation
is considered background radioactivity.
T4 and T3 tissue content
Animals were anesthetized and perfused via the vena cava with 5 ml
PBS containing 11 U heparin/ml, followed by 2 ml PBS; the portal vein
was used as an exit for the perfusate. Cortex, cerebellum, hippocampus,
and choroid plexus were dissected and frozen in dry ice. Samples were
kept at 270 C until use. T4 and T3 contents were determined by RIA after
extraction from tissue (28).
Northern blot analysis for RC3
RNA was isolated from brain using the Ultraspec RNA Isolation
System (Biotecx Laboratories, Inc., Houston, TX), and 20-mg RNA sam-
ples were subjected to electrophoresis and blotted on nylon membranes
using standard procedures. Probes were labeled using a random primer
labeling kit (Stratagene, La Jolla, CA).
A rat RC3 complementary DNA (cDNA) probe was used to detect
RC3 messenger RNA (mRNA) (29). Prehybridization was performed
for 5 h at 42 C in 50% formamide, 3 3 SSC (standard saline citrate),
5 3 Denhardt’s solution, 0.1% SDS, and 100 mg/ml salmon sperm
DNA, and hybridization was performed under the same conditions
for 20 h after the addition of 1 3 106 cpm probe/ml solution. Washes
were performed at room temperature in 1 3 SSC-0.1% SDS. A signal
was observed after 6 h.
The membrane was normalized with cyclophilin message, a ubiqui-
tous mRNA (30), using a rat cyclophilin cDNA probe. Prehybridization
was for 5 h at 39 C in 53% formamide, 0.75 m sodium chloride, 25 mm
PIPES (pH 6.8), 25 mm EDTA, 5 3 Denhardt’s solution, 0.1% SDS, and
100 mg/ml salmon sperm DNA, and hybridization was performed under
the same conditions for 20 h after the addition of 1 3 106 cpm probe/ml
solution. Washes were performed at room temperature in 2 3 SSC-0.1%
SDS and in 0.2 3 SSC-0.2% SDS at 60 C. Dr. J. G. Sutcliffe (The Scripps
Research Institute, La Jolla, CA) provided both the RC3 and cyclophilin
cDNAs.
D2 activity measurements
Hippocampus and cortex samples, pooled from three animals, and
individual cerebellum samples were homogenized in 470, 1000, and 350
ml 10 mm Tris-HCl (pH 7.2) and 0.25 m sucrose, respectively; and kept
at 270 C until use. A previously described procedure (31) was used, with
minor modifications. The 200-ml final mix consisted of 50 mm potassium
phosphate (pH 7.2), 1 mm propylthiouracil, 1 mm EDTA, 10 mm di-
thiothreitol, 8 nm T4, 2 mm T3, 800 mg homogenate protein, and 10
5 cpm
[125I]T4 (SA, 1250 mCi/mg; DuPont) previously purified on LH-20 Seph-
adex chromatography (32). Each sample, run in duplicate or triplicate,
was incubated for 60 or 90 min at 37 C. Two types of blanks were used,
some in which incubation was stopped at time zero by adding 100 ml
BSA (70 mg/ml) and 500 ml 10% trichloroacetic acid, and others in which
the homogenate was boiled before the addition of the labeled hormone
and then incubated for 60 or 90 min at 37 C. The reaction was stopped
by adding 100 ml BSA (70 mg/ml) and 500 ml 10% trichloroacetic acid.
Samples were centrifuged for 5 min at 3500–4500 rpm. Iodine produced
in the reaction was separated by Sephadex LH-20 chromatography (32).
Radioactivity was measured by g-spectrometry.
Protein concentrations were determined using a protein assay (Bio-
Rad Laboratories, Inc.) with albumin as standard.
Statistics
Group values, expressed as the mean 6 sd, were compared by Stu-
dent’s t test. P , 0.05 was considered statistically significant.
Results
In vitro choroid plexus synthesis of TTR
The absence of TTR in TTR-null choroid plexus was con-
firmed by metabolic labeling of choroid plexus explants.
Figure 1 indicates that despite an overload of TTR-null se-
cretion medium protein, no TTR was present in the choroid
plexus secretion medium of the TTR-null mouse (lane 2 vs.
lane 1). Identification of the TTR band in the wild-type cho-
roid plexus secretion medium (lane 1) and cells (lane 3) was
based on the migration of a TTR standard (lane 4). TTR was
absent in choroid plexus cells and CSF of the TTR-null mice
(data not shown). RT-PCR experiments further confirmed
the absence of TTR transcription in the TTR-null choroid
plexus (data not shown).
T4 binding to CSF proteins
The electrophoretic pattern of T4-binding proteins in ro-
dent serum is known (33). T4-binding globulin (TBG) mi-
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grates more slowly than albumin, whereas TTR runs slightly
faster than albumin, but cannot be resolved from albumin. As
previously described (24), Fig. 2A shows that in the wild-type
mouse, TTR and albumin were the major [125I]T4-binding
proteins (lane 3). The TTR-null mouse serum showed less
[125I]T4 binding at the albumin front, which corresponds to
TTR mobility, and an additional band in the TBG region of
the gel (lane 4). The appearance of the TBG band in the
TTR-null serum did not correspond to increased TBG con-
centration, but, rather, to the shift of the binding toward TBG
in the absence of TTR (24). In wild-type CSF, [125I]T4 labeling
occurred in the region where TTR and albumin overlapped
and appeared as a single band (lane 1). In TTR-null CSF (lane
2), [125I]T4 was recovered entirely in a band corresponding to
free [125I]T4 (lane 5).
In an independent experiment, bromophenol blue, a dye
that also binds to albumin, was included in the reaction
mixture before electrophoresis. The lack of a blue band is in
agreement with the absence of albumin in wild-type CSF
(data not shown).
Because in the experimental conditions used, TTR and
albumin cannot be resolved, we took advantage of the ability
of blue-Sepharose to bind albumin to discriminate between
TTR and albumin in wild-type CSF. The blue-Sepharose-
bound and -unbound fractions of wild-type or TTR-null CSF
were incubated with [125I]T4 and electrophoresed under na-
tive conditions. Figure 2B shows that no binding of [125I]T4
occurred to the blue-Sepharose-bound fraction in wild-type
CSF (lane 2), indicating the absence of albumin. On the other
hand, [125I]T4 bound to the blue-Sepharose-unbound wild-
type CSF fraction (lane 1) that contained TTR. These results
imply that TTR is the only T4-binding protein in wild-type
CSF. The blue-Sepharose-bound (lane 4) and -unbound (lane
3) fractions from the TTR-null CSF did not bind [125I]T4, as
all labels were recovered in the free [125I]T4 region (lane 5).
These observations further suggest the absence of T4-binding
protein in TTR-null CSF.
To confirm the absence of [125I]T4 binding in TTR-null CSF,
we chromatographed CSF after incubation with [125I]T4 on
Biogel P-6 DG. For wild-type mice, about 60% of the total
[125I]T4 were recovered in the protein-bound fraction. In con-
trast, only approximately 4% of the total [125I]T4 were re-
covered in the protein-bound fraction of the TTR-null CSF,
a value equivalent to the blank. Thus, both procedures in-
dicated that TTR-null CSF contains no T4-binding protein.
T4 and T3 tissue content
As shown in Table 1, no differences in T4 and T3 levels were
found between wild-type and the TTR-null mutant cortex,
cerebellum, and hippocampus. In TTR-null choroid plexus,
T4 and T3 levels were significantly reduced, amounting to
14% and 48% of wild-type values, respectively.
RC3-neurogranin message levels in brain
Message levels of RC3 are normally decreased in adult rat
brain in response to hypothyroidism (21). The expression of
the two transcripts of this gene between the wild-type and
TTR-null mice are compared in Fig. 3. No difference between
these groups was observed, indicating that the brain was
euthyroid with respect to this criterion.
FIG. 2. A, Autoradiogram showing [125I]T4 migration patterns af-
ter incubation with 1) wild-type CSF, 2) TTR-null CSF, 3) wild-type
serum, 4) TTR-null serum, and 5) buffer. In the wild-type CSF,
[125I]T4 binding occurs in the region where TTR and albumin mi-
grate (lane 1), whereas in the TTR-null CSF (lane 2), all radioac-
tivity is recovered in the free form (compare with lane 5 where only
buffer is present). Migration patterns of [125I]T4 in wild-type (lane
3) and TTR-null (lane 4) serum are shown for comparison (see
Results). B, Autoradiogram showing [125I]T4 migration patterns
after incubation with 1) wild-type CSF fraction unbound to blue-
Sepharose, 2) wild-type CSF fraction bound to blue-Sepharose, 3)
TTR-null CSF fraction unbound to blue-Sepharose, 4) TTR-null
CSF fraction bound to blue-Sepharose, and 5) buffer. In the wild-
type CSF, [125I]T4 binding is not seen in the blue-Sepharose-bound
fraction (lane 2), indicating the absence of albumin, whereas it
occurs to the blue-Sepharose-unbound fractions (lane 1) that con-
tains TTR. The blue-Sepharose-bound (lane 3) and -unbound (lane
4) fractions from the TTR-null CSF do not bind [125I]T4, as all labels
are recovered in the [125I]T4-free region (lane 5).
FIG. 1. SDS-PAGE analysis of in vitro labeled proteins of 1) wild-type
choroid plexus secretion medium, 2) TTR-null choroid plexus secre-
tion medium, and 3) wild-type choroid plexus cells. Lane 4 shows the
migration of 125I-radioladeled TTR and retinol-binding protein (RBP)
standards. Note that no TTR is secreted from TTR-null choroid
plexus.
THYROID HORMONES IN TRANSTHYRETIN-NULL MOUSE BRAIN 3269
 by on May 13, 2010 endo.endojournals.orgDownloaded from 
D2 activity measurements
D2 activities of brain regions were not statistically different
in TTR-null and wild-type mice (see Table 2). Further mea-
surements of deiodinase activity in synaptosomal fractions of
both cortex and hippocampus likewise revealed no differ-
ences between TTR-null and wild-type mice (data not
shown).
Discussion
We used a TTR-null mouse strain to study the role of TTR
in brain thyroid hormone homeostasis. The data presented
here indicate that in the absence of TTR, 1) the brain is
euthyroid and 2) the concentration of thyroid hormones is
significantly reduced in the choroid plexus, but not in the
brain parenchyma.
T4 binds only to TTR in the CSF of normal mice (8, 11).
Using two independent methods, we show that T4 is found
exclusively unbound in TTR-null mice. Thus, no other CSF
protein replaces TTR in the transport of T4.
T4 has been suggested to reach the brain through transport
of the serum free T4 fraction across the blood-brain barrier
(34) as well as by association with TTR through the blood-
choroid-plexus-CSF barrier (10, 12, 35). T4 bound to CSF TTR
could be delivered into different brain regions. Thus, after iv
injection of [125I]T4, radioactivity first appeared in the cho-
roid plexus, then in the CSF, and later in the cortex and
striatum of the brain (9, 10).
We previously showed that TTR is not absolutely required
for T4 to reach the brain (24). However, we also found that
whole brain total T4 levels were decreased in the TTR-null
mice (25). We report here that the T4 levels in cortex, hip-
pocampus, and cerebellum are normal. The decrease in T4
levels previously measured in whole brain can be accounted
for by the very marked reduction of T4 levels in the choroid
plexus of the TTR-null mice.
The TTR-bound fraction represents the major T4 pool in the
wild-type choroid plexus. Our results indicate that T4 can
enter the choroid plexus and, presumably, pass on into the
CSF in the absence of TTR. Thus, T4 entry into the choroid
plexus may derive from the free T4 pool. In fact, serum free
T4 is normal in the TTR-null sera (24).
Schreiber et al. (36) proposed that circulating T4-binding
proteins act as distributors of the hormone within the tissues.
They also suggested that, given the redundancy of T4-bind-
ing proteins (namely, T4-binding globulin, albumin, and
TTR), the absence of one protein would be compensated for
by the others. This concept of a protein network may apply
for serum (24). It cannot, however, apply for the blood-
choroid-plexus-CSF barrier, as we found no T4-binding pro-
tein in the CSF of TTR-null mice. Our results indicate that
CSF TTR is not required for normal maintenance of thyroid
hormone in brain. Whether the distribution of the hormone
in the brain is equivalent in the TTR-null and wild-type mice
is under investigation.
It has been suggested that one fifth of the T4 present in the
brain may originate from TTR-bound T4 transported from
the choroid plexus to the CSF (11). Our observations do not
support the idea that TTR constitutes a major route of T4
transfer into the brain parenchyma under normal physio-
logical conditions (9, 10). A direct measure of T4 levels in the
CSF of wild-type and TTR-null mice is, unfortunately, not
feasible, due to the large amounts of CSF required for the
analysis.
To evaluate further the thyroid hormone status of the
TTR-null mouse brain, we measured parameters known to be
affected in altered thyroid states. Thyroid hormones regulate
gene expression in the central nervous system, as in other
tissues, through transcriptional activation (15). Therefore, we
investigated the levels of steady state messenger RNA for
RC3, a gene whose expression is decreased in adult hypo-
thyroidism (21). Consistent with an euthyroid status, the
TABLE 2. Deiodinase type 2 activity in brain tissue homogenates
% 125I formed/
mg protein/time n
Wild-type cortex (60 min) 8.35 6 2.38 5
TTR-null cortex (60 min) 7.34 6 1.66 6
Wild-type hippocampus (60 min) 3.93 6 1.05 8
TTR-null hippocampus (60 min) 4.18 6 0.57 9
Wild-type cerebellum (90 min) 3.92 6 0.82 10
TTR-null cerebellum (90 min) 4.71 6 1.16 9
Values are the means 6 SD. No statistically significant differences
found.
TABLE 1. Thyroid hormone concentrations in brain regions and choroid plexus
Cortex Cerebellum
T4
(pg/mg protein)
n T3
(pg/mg protein)
n T4
(pg/mg protein)
n T3
(pg/mg protein)
n
Wild-type 97 6 34 9 114 6 36 9 116 6 30 9 55 6 19 9
TTR-null 81 6 24 9 106 6 24 9 103 6 17 9 57 6 13 9
Values are the means 6 SD.
a P , 0.01.
FIG. 3. Northern blot analysis of brain neurogranin message. Cyclo-
philin message normalizes the membrane RNA content on the same
membrane and demonstrates that the contents of both RC3 tran-
scripts are similar in TTR-null and wild-type mouse brains.
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levels of RC3 messenger RNA were normal in the TTR-null
brain.
The major portion of T3 in the brain is locally produced by
59-deiodination of T4 by D2 (17, 18). To guarantee a sufficient
supply of T3, the activity of D2 increases in hypothyroidism,
whereas D2 activity is decreased in hyperthyroidism (37, 38).
In the adult brain, D2 mRNA is expressed in the cerebellar
cortex, hippocampus, caudate-putamen, thalamus, and cer-
ebellum (39). We reported previously that despite decreased
whole brain total T4 levels in the TTR-null mice, their normal
whole brain T3 levels were not accounted for by increased D2
activity (24). However, as regional differences may have been
masked in the analysis of the whole brain, we performed
regional D2 analyses. No differences were found in D2 ac-
tivity in the cortex, cerebellum, and hippocampus of the
TTR-null compared with wild-type mice. In addition, T3
levels in the cortex, cerebellum, and hippocampus were
equivalent in wild-type and TTR-null mice. The greatly re-
duced T3 levels found in the TTR-null choroid plexus are
probably a direct consequence of the low total T4 levels found
in this epithelium. The presence of deiodinases in the choroid
plexus has not been reported. Taken together, our data pro-
vide strong evidence that the brain is euthyroid in the ab-
sence of TTR.
The normal free T4 serum levels in the TTR-null mice (24)
and the data presented here support the free hormone hy-
pothesis for T4 tissue uptake. In this hypothesis, the biolog-
ical activity of hormones is a function of their unbound (free),
rather than protein-bound, concentration (40).
We propose that under normal physiological conditions,
TTR has a storage role for T4 in blood, choroid plexus, and
CSF. This function may be relevant under conditions of in-
creased hormone demand. In the absence of TTR as a res-
ervoir in the choroid plexus and CSF, T4 exit from the CSF
to the cerebral and, ultimately, the general circulation might
be accelerated.
In summary, the data reported using TTR knockout mice
bear on the role of TTR in thyroid economy in brains of
normal mice. Because no other T4-binding protein replaces
TTR in the CSF and because a normal brain T4 content (aside
from the choroid plexus) is observed, we conclude that the
blood-choroid-plexus-CSF barrier plays no essential role in
entry or maintenance of T4 in the brain. If the TTR-null mouse
possesses compensatory mechanisms for brain CSF transport
and distribution in the absence of TTR, our studies to date
have not revealed them. To rule out the possibility that TTR
might account for some quantitative or qualitative aspects of
thyroid hormone transfer, we are investigating the distribu-
tion of radiolabeled T4 and T3 in the brains of TTR-null and
wild-type mice.
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